February 22, 2019
MD安德森’s proteomics platform provides a valuable institutional resource, complete with state-of-the-art instruments and specialized expertise to help researchers analyze and understand thousands of cancer-related proteins. These proteins may be useful as therapeutic targets, early detection signals or biomarkers of cancer treatment response for a number of disease types, including lung, colon, breast, ovarian, pancreatic, prostate...
February 18, 2019
Chronic lymphocytic leukemia (CLL), which originates in white blood cells known as lymphocytes, is the most common form of leukemia in adults...
BY吉尔罗素博士
February 13, 2019
胶质母细胞瘤是最常见的,脑癌的侵略性和致命的形式。原发性胶质母细胞瘤中位总生存期14.6个月〜
February 13, 2019
This is the second part of Cancer Frontline’s interview with Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology.
Sharma, along with Patrick Hwu, M.D., head of Cancer Medicine, and Jim Allison, Ph.D., chair of Immunology, leads the immunotherapy platform of MD Anderson’s Moon Shots Program™, a collaborative effort to accelerate the development of scientific discoveries into clinical...